Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 359 (RNA5SP359) is a human pseudogene related to the 5S ribosomal RNA gene family[2][3]. Pseudogenes are defective gene copies that have lost their ability to code for functional RNA or protein, usually due to mutations or lack of regulatory elements[3]. The canonical, functional 5S ribosomal RNA is a short (about 120 nucleotides) non-coding RNA that is a vital structural and functional component of the ribosome, necessary for protein synthesis in all life domains except some mitochondria[1][5]. However, RNA5SP359 does not produce a functional 5S rRNA molecule and is not known to be transcribed into a stable RNA or protein product. Pseudogenes as a class can occasionally act as regulatory RNAs or affect gene expression, and global pseudogene expression profiles have been explored as biomarkers and molecular classifiers in cancer biology[6]. There is currently no evidence that RNA5SP359 has a known function, disease association, or utility as a drug target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 359 (RNA5SP359).